Skip to content
Clinical Trials – home

Belinus Bt.

Research site

Hungary Erzsebet Utca 11-13, 4025 Debrecen, Hungary

  • Atrial fibrillation · Obesity · Type 2 diabetes mellitus
  • Adult patients

About Specializations

Belinus Bt. in Debrecen, Hungary specialises in clinical trials of conditions such as Atrial fibrillation, Obesity, Type 2 diabetes mellitus, Overweight, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

At Belinus Bt. in Debrecen, research in Cardiovascular Diseases focuses mainly on Atrial Fibrillation and related bleeding risk management. The trials are designed to compare treatments and improve the safety of care for people with heart rhythm disorders.

  • Evaluating a new therapy for Atrial Fibrillation against standard anticoagulation
  • Studying the balance between preventing clots and reducing bleeding complications

This work aims to support better treatment choices for patients who need long-term cardiovascular protection.

Nutritional and Metabolic Diseases

Clinical trials in Nutritional and Metabolic Diseases cover Type 2 diabetes, Obesity, Overweight, Hyperlipidemia, and Severe Hypertriglyceridemia. The studies are testing new approaches to improve blood sugar control, reduce body weight, and lower harmful blood lipids.

  • Assessing therapies for Type 2 diabetes when diet and exercise are not enough
  • Testing treatments for Obesity and Overweight to support weight loss
  • Evaluating options for Hyperlipidemia and severe triglyceride reduction

The overall goal is to find more effective ways to manage metabolic disease and its common complications.

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Research in Congenital, Hereditary, and Neonatal Diseases and Abnormalities is represented more broadly at this site and may reflect trials with complex or overlapping disease areas rather than a single condition. The focus is on understanding treatment effects in patients with chronic health problems that can involve inherited or early-life risk factors.

  • Exploring broader disease patterns linked to long-term metabolic and cardiovascular risk
  • Supporting research that may inform care across multiple patient groups

This area adds depth to the site’s portfolio by connecting specialized research with wider clinical needs.

Otorhinolaryngologic Diseases

The site also includes Otorhinolaryngologic Diseases within its research profile, although this appears less prominent than the metabolic and cardiovascular studies. The available trials suggest a broader clinical environment that may support diverse patient populations and related health concerns.

  • Contributing to a varied clinical research portfolio
  • Supporting investigation of conditions outside the main metabolic focus

These studies help broaden understanding of treatment needs across different medical specialties.

Other and Unspecified Research Areas

Some trials at Belinus Bt. fall into categories that are not fully specified, showing a flexible research program that can adapt to different clinical questions. These studies still center on practical goals such as testing new therapies, improving disease control, and comparing treatment effectiveness.

  • Investigating new options for chronic disease management
  • Comparing therapies with placebo or established treatments
  • Generating evidence to guide everyday clinical decisions

Together, these projects reflect an active site contributing to both targeted and broader clinical research in Hungary.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Erzsebet Utca 11-134025 DebrecenHungary
Recruiting now
no trials
Conditions studied
12

More sites in DebrecenHungary

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

11 clinical trials

Type 2 diabetes mellitus+3

Not recruiting

A study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Study of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:ISIS 678354 sodium salt
  • Sponsor:Ionis Pharmaceuticals Inc.

Arteriosclerosis

Not recruiting

Study on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Obicetrapib
  • Sponsor:NewAmsterdam Pharma B.V.

Atrial fibrillation

Not recruiting

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen Cilag International

A study testing cagrilintide and semaglutide compared to placebo in people with type 2 diabetes not well controlled by diet and exercise

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Hyperlipidaemia

Not recruiting

A Study of Enlicitide and Rosuvastatin for Adults With High Cholesterol

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years
  • Substances:Rosuvastatin Zinc
  • Sponsor:Merck Sharp & Dohme LLC

Type 2 diabetes mellitus+1

Not recruiting

Study on the Effectiveness of Survodutide for Weight Loss in Patients with Type 2 Diabetes and Obesity

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim Espana S.A.

Obesity+1

Not recruiting

Study on the Effects of PF-07976016 and Liraglutide in Adults with Obesity

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Liraglutide
  • Sponsor:Pfizer Inc.

Atrial fibrillation

Not recruiting

Study on the Safety and Tolerability of Abelacimab Compared to Rivaroxaban in Patients with Atrial Fibrillation

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Study on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Sponsor:Merck Sharp & Dohme LLC

Atrial fibrillation+2

Not recruiting

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.